Drug
Immune Globulin Human
Immune Globulin Human: highest development phase Phase 2, developed by Grifols. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified NCT00220805 | Phase 2 | Macular Degeneration |
| Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified NCT00220779 | Phase 2 | Multiple Sclerosis, Relapsing-Remitting |
Latest
No recent events.
Follow Immune Globulin Human on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.